Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - imunologiniai vaistai - vištiena - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - vištiena - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

zoetis belgium - inactivated mycoplasma hyopneumoniae, strain p-5722-3, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (orf2) protein, inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b orf2 protein - imunologiniai vaisiai suidae - kiaulių (mėsiniai) - active immunisation of pigs against porcine circovirus type 2 to reduce viral load in blood and lymphoid tissues, fecal shedding and the lesions in lymphoid tissues associated with pcv2 infection. protection was demonstrated against porcine circovirus types 2a, 2b and 2d. active immunisation of pigs against mycoplasma hyopneumoniae to reduce the lung lesions associated with mycoplasma hyopneumoniae infection.  onset of immunity (both vaccination schedules): 3 weeks after (the last) vaccination.  duration of immunity (both vaccination schedules): 23 weeks after (the last) vaccination.  in addition, vaccination has been shown to reduce body weight gain losses under field conditions.

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

fresenius kabi ab - alaninas/argininas/glicinas/histidinas/izoleucinas/leucinas/lizinas/metioninas/fenilalaninas/prolinas/serinas/taurinas/treoninas/triptofanas/tirozinas/valinas/kalcio chloridas dihidratas/natrio glicerofosfatas hidratas/magnio sulfatas heptahidratas/kalio chloridas/natrio acetatas trihidratas/cinko sulfatas heptahidratas/gliukozė, monohidratas/sojų aliejus, rafinuotas/trigliceridai, vidutinės grandinės/alyvuogių aliejus, rafinuotas/Žuvų taukai, praturtinti omega-3 rūgštimis - infuzinė emulsija - 4,7 g/4,1 g/3,7 g/1 g/1,7 g/2,5 g/2,2 g/1,5 g/1,7 g/3,8 g/2,2 g/0,34 g/1,5 g/0,68 g/0,14 g/2,1 g/0,19 g/1,4 g/0,41 g/1,5 g/1,1 g/0,0044 g/89 g/12 g/12 g/9,8 g/5,9 g/ml; 4,7 g/4,1 g/3,7 g/1 g/1,7 g/2,5 g/2,2 g/1,5 g/1,7 g/3,8 g/2,2 g/0,34 g/1,5 g/0,68 g/0,14 g/2,1 g/0,19 g/1,4 g/0,41 g/1,5 g/1,1 g - combinations

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

hipra human health s.l. - sars-cov-2 virus recombinant spike (s) protein receptor binding domain (rbd) fusion heterodimer – b.1.351-b.1.1.7 strains - covid-19 virus infection - vakcinos - bimervax is indicated as a booster for active immunisation to prevent covid-19 in individuals 16 years of age and older who have previously received a mrna covid-19 vaccine.

Ευρωπαϊκή Ένωση - Λιθουανικά - EMA (European Medicines Agency)

teva b.v. - rasagilinas - parkinsono liga - anti-parkinsono vaistai - azilect fluorouracilu ir folino idiopatine parkinsono liga (pd) monotherapy (be levodopa) arba kaip priedas terapija (su levodopa) pacientams, sergantiems pabaigos dozės svyravimai.

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

pharmaceutical works polpharma s.a. - razagilinas - tabletės - 1 mg - rasagiline

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

pharmaswiss Česká republika s.r.o. - razagilinas - tabletės - 1 mg - rasagiline

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

krka, d.d., novo mesto - razagilinas - tabletės - 1 mg - rasagiline

Λιθουανία - Λιθουανικά - SMCA (Valstybinė vaistų kontrolės tarnyba)

medochemie ltd. - razagilinas - tabletės - 1 mg - rasagiline